Raymond James Financial’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$70.6K Sell
6,288
-5,000
-44% -$56.2K ﹤0.01% 4979
2025
Q1
$51.6K Buy
+11,288
New +$51.6K ﹤0.01% 4583